3Athyros VG,Mikhailidis DP,Liberopoulos EN,et al.Effect of statin treatment on renal function and serum u-ric acid levels and their relation to vascular events inpatients with coronary heart disease and metabolic syn-drome:a subgroup analysis of the GREek Atorvastatinand Coronary Heart Disease Evaluatio. Nephrology Dialysis Transplantation . 2007
4Borghi C,Domi A,Veronesi M,et al.Association be-tween different lipid lowering treatment strategies andblood pressure control in Brisighella Heart Study. American Heart Journal . 2004
5Shah S,Paparello J,Danesh FR,et al.Effects of statintherapy on the progression of chronic kidney disease. Adv Chronic Kidney Dis . 2005
6Epstein M,CampeseVM.Pleiotropic effects of 3-hydrox-y-3-methylglutaryl coenzyme a reductase inhibitors onrenal function. American Journal of Kidney Diseases . 2005
7Patti G,Chello M,Pasceri V,et al.Protectionfromproceduralmyocardial injury by atorvastatin is associated with lower ofadhesion molecules after percutaneous coronary intervention:results fromthe ARMYDA-CAMs(Atorvastatinfor Reductionof Myocardial Damage during Angioplasty-cell AdhesionMole. Journal of the American College of Cardiology . 2006
8Ferrier KE,Muhlmann MH,Baguet JP,et al.Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension. Journal of the American College of Cardiology . 2002
9Zhou,MS,Jaimes,EA,Raij,L.Atorvastatin prevents end-organ injury in salt-sensitive hypertension. Journal of Hypertension . 2004
10Lee TM,Lin MS,Tsai CH,et al.Add-on and withdrawal effect of pravastatin on proteinuria in hypertensive patients treated with AT receptor blockers. Kidney International . 2005
3KAGAMI S,BORDER W A,MILLER D E,et al.Angiotensin Ⅱ stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells[J].J Clin Invest,1994,93 (6):2431-2437.
4TEICHER B A.The transform in growth factor beta proteins:discoveries and insights[J].Cancer Metasis Rev,2001,20(1):133.
5KANETO H,MORRISSEY J,KLAHR S.Increased expression of TGFbeta1 mRNA in the obstructed kidney of rats with unilateral ur2eteral ligation[J].Kidney Int,1993,44(2):313-321.
6EPSTEIN M,CAMPESE V M.Pleiot ropic effects of 3-hydroxy3-methylglutaryl coenzyme a reductase inhibitors on renal function[J].Am J Kidney Dis,2005,45(1):2-14.
7SHAH S,PAPARELLO J,DANESH F R.Effects of statin therapy on the progression of chronic kidney disease[J].Adv Chronic Kidney Dis,2005,12(2):187-195.
5TanakaA,Suemam K,Otsuka T,et al.Estimation of the initial dose setting ofvancomycin therapy usingcystain C as a new marker of renal function [J]. TherDrug Monit.2007,29(2),261-264.
